(30 days)
No
The 510(k) summary describes a physical implantable device (screw and washer) made of a specific material, with modifications related to its physical design and associated instruments. There is no mention of software, algorithms, data processing, or any terms related to AI/ML.
Yes
The device is described as maintaining proximity between soft tissue and bone to facilitate soft tissue reattachment and is implanted in the body for therapeutic purposes (healing of tendon lesions).
No
The device, BioCuff C™, is an implantable screw and washer system designed to reattach soft tissue to bone. It facilitates healing rather than diagnosing a condition.
No
The device description clearly outlines a physical implant (screw and washer) made of poly-L/D-lactide copolymer, along with associated surgical instruments. There is no mention of software as the primary or sole component of the device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Description and Intended Use: The description clearly states that the BioCuff C™ is a screw/washer combination made of poly-L/D-lactide copolymer intended for surgical implantation to maintain proximity between soft tissue and bone. This is a physical implant used within the body, not a device used to test samples outside the body.
The text describes a surgical implant used for musculoskeletal repair, which falls under a different category of medical devices than IVDs.
N/A
Intended Use / Indications for Use
Properly used, in the presence of adequate immobilization, absorbable BioCuff CM screw/washer maintains proximity between soft tissue and bone to facilitate the soft tissue reattachment. BioCuff C™ loses its strength over 20 to 50 weeks while the lesion of the tendon is healing. This indication is completely identical with the previously cleared BioCuffM (K001378).
The BioCuff C™ is not intended for use in and is contraindicated for: 1) Insufficient quality or quantity of bone, 2) Foreign body sensitivity to the implant material. Where the material is suspected a test should be made prior to implantation to rule out sensitivity. 3) Patients with active sepsis or infection. 4) Conditions, which tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing and rehabilitation period.
Product codes
MAJ, HWC
Device Description
BioCuff CTM is composed of poly-L/D-lactide copolymer. This raw material is completely identical with the previously cleared Bionx Implants Inc. BioCuff™ (K001378).
The device description of BioCuff C™ screw and washer combination is as follows:
- Composed of poly-L/D-lactide copolymer -
- -Lengths 18, 28 and 36mm.
- Diameter 6.0 mm -
- -Cannulation for 1.5mm K-wire
The only modifications that were made are:
- Cannulated design for easier installation of the product u
- Increased outer diameter -
- Minor design changes in head of the screw and washer accordingly -
- Revision of instrument set according to needs of cannulation. This means cannulated screwdriver, cannulated drill, grasper, cannulated bone tap, sterilization tray and K-wire. Instrument set is substantially equivalent to previously cleared Bionx Implants Inc. BioCuff™ screw/washer (K001378) and Cannulated SmartScrew (K974876, K992947).
- Introduction of new reference numbers -
- Introduction of new trade name, BioCuff CTM -
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissue and bone, tendon
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
K013057
10FD
510(k) Summary Bionx Implants Inc. BioCuff CTM
Submitter's Name, Address, Telephone Number, and Contact I'crson
Bionx Implants, Inc. 1777 Sentry Parkway West Gwynedd Hall, Suite 400 Blue Bell, PA 19422
Contacts:
Gerard S. Carlozzi President and Chief Executive Officer Phone: (215) 643-5000 (215) 653-0984 Facsimile:
Bionx Implants Ltd. Tuija Annala Director, Quality and Regulatory Affairs P.O.Box 3 FIN-33721 Tampere Finland Phone: 358-3-316 5679 Facsimile: 358-3-316 5629
Date prepared: August 30, 2001
Name of the device:
- Trade or Proprietary Name: BioCuff CTM A. B. Common Name: Bioabsorbable soft tissue fixation fastencr C. Classification Name: Bioabsorbable soft tissue fixation fastener D. Device Product Code: MAJ
Predicate Device:
Bionx Implants Inc. BioCuff™ (K001378)
Intended Use:
Properly used, in the presence of adequate immobilization, absorbable BioCuff CM screw/washer maintains proximity between soft tissue and bone to facilitate the soft tissue reattachment. BioCuff C™ loses its strength over 20 to 50 weeks while the lesion of the tendon is healing. This indication is completely identical with the previously cleared BioCuffM (K001378).
1
K013057
20F2
Also, like the predicate devices, the BioCuff C™ is not intended for use in and is contraindicated for:
- Surgical procedures other than those listed. 】.
- Conditions that may compromise fixation with BioCuff CTM (osteopenic, 2. comminuted bone, etc.).
- Conditions that may retard healing (poor blood supply, past or potential ਲ, infection, elc.).
- Active infection. 4.
- Conditions that may limit the patient's ability or willingness to restrict న్. activities or follow directions during the healing period.
- Foreign body sensitivity to materials. 6.
Device Description:
BioCuff CTM is composed of poly-L/D-lactide copolymer. This raw material is completely identical with the previously cleared Bionx Implants Inc. BioCuff™ (K001378).
The device description of BioCuff C™ screw and washer combination is as follows:
- Composed of poly-L/D-lactide copolymer -
- -Lengths 18, 28 and 36mm.
- Diameter 6.0 mm -
- -Cannulation for 1.5mm K-wire
The only modifications that were made are:
- Cannulated design for easier installation of the product u
- Increased outer diameter -
- Minor design changes in head of the screw and washer accordingly -
- Revision of instrument set according to needs of cannulation. This means cannulated screwdriver, cannulated drill, grasper, cannulated bone tap, sterilization tray and K-wire. Instrument set is substantially equivalent to previously cleared Bionx Implants Inc. BioCuff™ screw/washer (K001378) and Cannulated SmartScrew (K974876, K992947).
- Introduction of new reference numbers -
- Introduction of new trade name, BioCuff CTM -
Substantial Equivalence:
The minor technological differences between BioCuff CTM and the predicate device do not raise any new issues of safety or effectiveness.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is circular and features the department's name around the perimeter. In the center is a stylized emblem consisting of three curved shapes, resembling a bird or abstract design. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 1 2 2001
Mrs. Tuija Annala Director, Quality and Regulatory Affairs Bionx Implants Ltd. Hermiankatu 6-8 L Tampere Finland
Re: K013057
Trade Name: BioCuff CTM Regulation Number: 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: II Product Code: MAI, HWC Dated: September 6, 2001 Received: September 6, 2001
Dear Mrs. Tuija Annala:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your becaon 910(t) proxime is substantially equivalent (dor in indications felerenced above and nave determined by marketed predicate devices marketed in interstate for use stated in the encrosule) to regally manetical povice Amendments, or to commence prior to May 20, 1976, the encordance with the provisions of the Federal Food, Drug, devices that have been reciasined in asses approval of a premarket approval application (PMA). allo Cosmetic Act (71ct) that ao nov requestly of the general controls provisions of the Act. The I ou may, increrore, market the act include requirements for annual registration, listing of general controls provisions of ractice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (600 as voyols. Existing major regulations affecting your device can thay be subject to subli additions, Title 21, Parts 800 to 898. In addition, FDA may ou louica in the overnments concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean I loast be advisou that I Dr brains that your device complies with other requirements of the Act that I Dri has made a aver mixalations administered by other Federal agencies. You must or any I carated and the Act's requirements, including, but not limited to: registration and listing (21 Comply with an the rece or of an entry (1) ; good manufacturing practice requirements as set CFR Part 6077; adoning (21 CFR Part 820); and if applicable, the electronic forth in the quality by sections (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mrs. Tuija Annala
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sincerely yours,
Mark McMillan
Celia M. Witten, Ph.D., MD Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
510(K) Number (if known): K013057
Device Name:
BioCuff Circ
Indications for Use:
Properly used, in the presence of adequate immobilization, absorbable BioCull CM screw/washer maintains proximily between soft tissue and bone to facilitate the soft tissue reattachment. The BioCuff C™ Ioses its strength over 20 to 50 weeks while the Icsion of the tendon is healing.
The BioCuff C™ is not intended for use in and is contraindicated for: 1) Insufficient quality or quantity of bone, 2) Foreign body sensitivity to the implant material. Where the material is suspected a test should be made prior to implantation to rule out sensitivity. 3) Patients with active sepsis or infection. 4) Conditions, which tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing and rehabilitation period.
(Please do not write below this line - continue on another page is needed) Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR Over-The-Counter Use_
for Mark N Milkman
10(k) Number K013057